There are other available p-tau epitopes, including plasma p-tau181, which was the first p-tau measured in AD patients’ plasma [25], p-tau205 [24], an epitope with higher potential impact in later stages of the disease [26], and p-tau212 [19]. This evidence concerns the gene MAPT and Alzheimer disease.